ORIGINAL RESEARCH article
Front. Immunol.
Sec. Viral Immunology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1593820
This article is part of the Research TopicAnimal-borne viral disease: Pathogenesis, Innate immunity, Acquired immunity, and Novel vaccine developmentView all 15 articles
Maternal Immunity and African swine fever virus: Understanding the limits of passive protection
Provisionally accepted
- 1Institute of Diagnostic Virology, Federal Research Institute for Animal Health, Friedrich-Loeffler-Institut, Greifswald, Germany
- 2Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Greifswald – Island of Riems, Germany
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
African swine fever (ASF) is an often-fatal disease impacting domestic and wild pigs world-wide. Understanding the role of maternal immunity in ASF pathogenesis is crucial for effective control. This study characterized kinetics and protective potential of maternal immunity against ASF virus (ASFV) in neonatal piglets. Two times ten sows were inoculated with the moderately virulent ASFV strain ‘Estonia2014’, all developed typical ASF signs and viraemia; five animals recovered. The offspring of two recovered sows (n = 24) were sampled weekly to monitor maternal ASFV-specific antibody kinetics. The offspring of two other sows, in addition to piglets of an ASFV-naïve sow, were challenged oro-nasally with the highly virulent ASFV strain ‘Armenia2008’ on the seventh day of life. To evaluate the impact of ASFV-specific antibodies without ASFV-specific T cells, five piglets from the naïve sow received purified, concentrated immunoglobulins from ASFV-immune pigs via serum transfer prior to challenge infection. All naïve piglets (n = 12), regardless of immunoglobulin transfer, reached the humane endpoint 6 days post inoculation (dpi). Piglets of immune sows began displaying clinical signs 5 dpi, and all either succumbed or reached the humane endpoint by 9 dpi (n = 27). Serology confirmed antibodies against ASFV (p32, p72) in all piglets of immune sows. Antibody titers in unchallenged piglets remained stable for at least 60 days after birth. In challenged piglets, those of immune sows were initially seropositive but mostly seronegative after challenge, indicating antibody consumption. Passively transferred antibodies were also depleted after challenge. In conclusion, passively acquired immunity, whether through immunoglobulin transfer (antibodies) or colostrum (antibodies and lymphocytes), is insufficient to safeguard neonatal pigs from lethal infection with highly virulent ASFV.
Keywords: African Swine Fever, African Swine Fever Virus, Antibodies, Maternal immunity, Humoral immune response
Received: 14 Mar 2025; Accepted: 07 Jul 2025.
Copyright: © 2025 Friedrichs, Streitz, Beer, Blome and Schäfer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Sandra Blome, Institute of Diagnostic Virology, Federal Research Institute for Animal Health, Friedrich-Loeffler-Institut, Greifswald, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.